Decision analytic modeling

International Encyclopedia of Public Health

Volumn , Issue , 2008, Pages 71-76

  Muenning, P ^a  

^a Columbia University ^*  (United States)

Author keywords

Decision analysis; Expected value; Health related quality of life; Markov modeling; Monte carlo simulation; Quality adjusted life years; Sensitivity analysis

Indexed keywords

EID: 84884455579     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012373960-5.00332-4     Document Type: Chapter

References (20)

1. Drummond M.F., O'Brien B.O., Stoddart G.L., Torrance G.W. Methods for the Economic Evaluation of Health Care Programmes 2005, Oxford University Press, London. 3rd edn.
2. Farmer P. Pathologies of Power: Health, Human Rights, and the New War on the Poor 2004, University of California Press, Berkeley, CA.
3. Gold M., Siegel J., Russell L., Weinstein M. Cost-Effectiveness in Health and Medicine 1996, Oxford University Press, New York.
4. Gold M.R., Franks P., McCoy K.I., Fryback D.G. Toward consistency in cost-utility analyses: Using national measures to create condition-specific values. Medical Care 1998, 36(6):778-792.
5. Gold M.R., Muennig P. Measure-dependent variation in burden of disease estimates: Implications for policy. Medical Care 2002, 40(3):260-266.
6. Halpern E.F., Weinstein M.C., Hunink M.G., Gazelle G.S. Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients. Medical Decision Making 2000, 20(3):314-322.
7. Mandelblatt J.S., Schechter C.B., Yabroff K.R., et al. Benefits and costs of interventions to improve breast cancer outcomes in African American women. Journal of Clinical Oncology 2004, 22(13):2554-2566.
8. Muennig P. Cost-Effectiveness Analysis in Health, a Practical Approach 2007, Jossey-Bass, San Francisco, CA.
9. Muennig P., Pallin D., Sell R.L., Chan M.S. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. New England Journal of Medicine 1999, 340(10):773-779.
10. Muennig P., Pallin D., Challah C., Khan K. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States. Epidemiology and Infection 2004, 132(6):1055-1063.
11. Muennig P., Franks P., Gold M. The cost effectiveness of health insurance. American Journal of Preventive Medicine 2005, 28(1):59-64.
12. Muennig P.A., Khan K. Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults. Clinical and Infectious Disease 2001, 33(11):1879-1885.
13. Sonnenberg F.A., Beck J.R. Markov models in medical decision making: A practical guide. Medical Decision Making 1993, 13(4):322-338.
14. Drummond M.F., O'Brien B.O., Stoddart G.L., Torrance G.W. Methods for the Economic Evaluation of Health Care Programmes 2005, Oxford University Press, London. 3rd edn.
15. Cost-Effectiveness in Health and Medicine 1996, Oxford University Press, New York. M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein (Eds.).
16. Hunink M., Glasziou P., Siegel J.E., et al. Decision Making in Health and Medicine 2001, Cambridge University Press, Cambridge, UK.
17. Muennig P. Designing and Conducting Cost-Effectiveness Analysis in Health and Medicine 2002, Jossey-Bass, San Francisco, CA.
18. Muennig P. Cost-Effectiveness Analysis in Health, a Practical Approach 2007, Jossey-Bass, San Francisco, CA.
19. Sonnenberg F.A., Beck J.R. Markov models in medical decision making: A practical guide. Medical Decision Making 1993, 13(4):322.
20. Weinstein M.C., Fineberg H.V., Elstein A.S., et al. Clinical Decision Analysis 1980, W. B. Saunders, Philadelphia, PA.